Dan Pu
Impact in
-
- Eicosanoids and Hypertension Pharmacology
Papers in
- Co-authors
- Yuedan Wang (1 shared paper)Wang Xian (1 shared paper)Yun Wang (1 shared paper)Ju‐Hua Ni (1 shared paper)Li‐Ling Wu (1 shared paper)Weiguang Zhang (1 shared paper)Yuwen Zhou (3 shared papers)Liang Cai (1 shared paper)
- Journals
- Translational Lung Cancer Research (3 papers)BMC Medical Education (2 papers)Frontiers in Immunology (2 papers)Clinical Rheumatology (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Dan Pu
25 papers receiving 339 citations
Peers
Comparison fields: 5 of 91
- Biochemistry 30
- Hepatology 19
- Oncology 55
- Pharmacology 33
- Genetics 20
Countries citing papers authored by Dan Pu
This map shows the geographic impact of Dan Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Pu more than expected).
Fields of papers citing papers by Dan Pu
This network shows the impact of papers produced by Dan Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Pu. The network helps show where Dan Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 104 | |
| 2 | 2020 | 63 | |
| 3 | 2012 | 48 | |
| 4 | 2015 | 21 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 15 | |
| 7 | 2010 | 13 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 9 | |
| 10 | 2022 | 7 | |
| 11 | 2019 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2017 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2024 | 2 |
About Dan Pu
Dan Pu is a scholar working on Surgery, Oncology, Rheumatology, Immunology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 346 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Systemic Lupus Erythematosus Research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Simulation-Based Education in Healthcare (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Smart Parking Systems Research (1 paper), Management of metastatic bone disease (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Biochemistry (30 citations), Hepatology (19 citations), Oncology (55 citations), Pharmacology (33 citations) and Genetics (20 citations). Dan Pu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yuedan Wang, Wang Xian, Yun Wang, Ju‐Hua Ni, Li‐Ling Wu, Weiguang Zhang, Yuwen Zhou, Liang Cai, Liyuan Yin and Lin Huang. Their work appears in journals such as Translational Lung Cancer Research, BMC Medical Education, Frontiers in Immunology, Clinical Rheumatology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.